Your browser doesn't support javascript.
loading
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain.
Martínez López, Icíar; Gómez Cerezo, Jorge Francisco; Gámez, José M; Egocheaga Cabello, Isabel; Castellanos, Mar; Campuzano Ruiz, Raquel; Barrios, Vivencio; Pallarés-Carratalá, Vicente; Rodríguez, José Manuel; Morant Talamante, Nuria; Parrondo, Javier; Mostaza, José María.
Afiliação
  • Martínez López I; Pharmacy Service and Molecular Diagnostics and Clinical Genetics Unit, Hospital Universitario Son Espases, Balearic Islands, Palma de Mallorca, Spain.
  • Gómez Cerezo JF; Internal Medicine Service, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, Madrid, Spain.
  • Gámez JM; Cardiology Service, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
  • Egocheaga Cabello I; Department of Medicine, Universidad de las Islas Baleares, Palma de Mallorca, Spain.
  • Castellanos M; CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN CB 12/03/30038), Instituto de Salud Carlos III, Madrid, Spain.
  • Campuzano Ruiz R; Family Medicine Service, Health Center of Isla de Oza, Madrid, Spain.
  • Barrios V; Department of Neurology, University Hospital and Biomedical Research Institute, A Coruña, Spain.
  • Pallarés-Carratalá V; Cardiac Rehabilitation, Cardiology Service, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Rodríguez JM; Hospital Universitario Ramón y Cajal and Medicine and Medical Specialties Department, Universidad de Alcalá de Henares, Madrid, Spain.
  • Morant Talamante N; Health Surveillance Unit, Unión de Mutuas, Castellón, Spain.
  • Parrondo J; Medicine Department, Universitat Jaume I, Castellón, Spain.
  • Mostaza JM; Medicine Department, Universitat Jaume I, Castellón, Spain.
Front Cardiovasc Med ; 11: 1324537, 2024.
Article em En | MEDLINE | ID: mdl-38481954
ABSTRACT

Introduction:

Atherosclerotic cardiovascular disease (ASCVD) is one of the main causes of morbidity and mortality in developed countries and entails high resources use and costs for health systems. The risk of suffering future cardiovascular (CV) events and the consequent resources use is higher in those patients who have already had a previous cardiovascular event. The objective of the study was to determine the average annual cost of patients with a new or recurrent atherosclerotic CV event during the 2 years after the event.

Methodology:

Retrospective observational study of electronic medical records of patients from the BIG-PAC® database (7 integrated health areas of 7 Autonomous Communities; n = 1.8 million). Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec-2018 were included. The resources use within two years of the diagnosis was estimated in order to estimate the average cost of patient follow-up.

Results:

A total of 26,976 patients with an ASCVD episode were identified during the recruitment period; Out of them, 6,798 had a recurrent event during the follow-up period and 2,414 died. The average costs per patient were €11,171 during the first year and €9,944 during the second year.

Discussion:

Patients with ASCVD represent a significant economic burden for the health system and for society. Despite the perception that drug costs in the follow-up of chronic patients imply a high percentage of the costs, these accounted for only one tenth of the total amount. Implementing preventive programs and increasing the control of cardiovascular risk factors may have a significant social and health impact by helping to reduce mortality and costs for the Spanish National Health System. The costs derived from pharmacological treatments were obtained from the NHS pricing nomenclator database (https//www.sanidad.gob.es/profesionales/nomenclator.do).
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha